IONS - IONIS PHARMACEUTICALS INC

QQQ $ 625.17 $ 0.00 (0 %)

DIA $ 473.75 $ 0.00 (0 %)

SPY $ 679.40 $ 0.00 (0 %)

TLT $ 89.36 $ 0.00 (0 %)

GLD $ 369.30 $ 0.00 (0 %)

Previous Close

$ 74.68

Open

$ 72.14

Bid

$ 72.60 x 14

Ask

$ 75.80 x 2

Day's Range

-- - --

52 Week Range

$ 23.95 - $ 75.49

Volume

2,259,305

Average Volume

Market Cap

Beta (5Y Monthly)

$ 0.71

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-29-2025	09-30-2025	10-Q
2	07-30-2025	06-30-2025	10-Q
3	04-30-2025	03-31-2025	10-Q
4	02-19-2025	12-31-2024	10-K
5	11-06-2024	09-30-2024	10-Q
6	08-01-2024	06-30-2024	10-Q
7	05-07-2024	03-31-2024	10-Q
8	02-21-2024	12-31-2023	10-K
9	11-02-2023	09-30-2023	10-Q
10	08-09-2023	06-30-2023	10-Q
11	05-03-2023	03-31-2023	10-Q
12	02-22-2023	12-31-2022	10-K
13	11-09-2022	09-30-2022	10-Q
14	08-09-2022	06-30-2022	10-Q
15	05-04-2022	03-31-2022	10-Q
16	02-24-2022	12-31-2021	10-K
17	11-03-2021	09-30-2021	10-Q
18	08-04-2021	06-30-2021	10-Q
19	05-05-2021	03-31-2021	10-Q
20	02-24-2021	12-31-2020	10-K
21	11-04-2020	09-30-2020	10-Q
22	08-05-2020	06-30-2020	10-Q
23	05-06-2020	03-31-2020	10-Q
24	03-02-2020	12-31-2019	10-K
25	11-06-2019	09-30-2019	10-Q
26	08-08-2019	06-30-2019	10-Q
27	05-09-2019	03-31-2019	10-Q
28	03-01-2019	12-31-2018	10-K
29	11-06-2018	09-30-2018	10-Q
30	08-07-2018	06-30-2018	10-Q
31	05-07-2018	03-31-2018	10-Q
32	02-28-2018	12-31-2017	10-K
33	11-07-2017	09-30-2017	10-Q
34	08-09-2017	06-30-2017	10-Q
35	05-09-2017	03-31-2017	10-Q
36	03-01-2017	12-31-2016	10-K
37	11-09-2016	09-30-2016	10-Q
38	08-09-2016	06-30-2016	10-Q
39	05-05-2016	03-31-2016	10-Q
40	02-26-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Ionis Pharmaceuticals Releases Long-Term D...
11/06/2025 13:19:45

DAWNZERA showed durable efficacy, demonstrating 94% overall mean HAE attack rate reduction at one year in OASISplus open-label ...

cathie-wood-goes-all-in-on-peter-thiels-crypto-play-bullish-with-back-to-back-million-dollar-buys

Cathie Wood Goes All-In On Peter Thiel's C...
11/05/2025 01:42:01

Cathie Wood-led Ark Invest purchased shares in Bullish, a crypto exchange backed by Peter Thiel, through three of its funds. Ot...

Piper Sandler Maintains Overweight on Ioni...
11/04/2025 16:33:16

Piper Sandler analyst Allison Bratzel maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price t...

TD Cowen Maintains Buy on Ionis Pharmaceut...
10/30/2025 20:07:50

TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target from $59 ...

Morgan Stanley Maintains Overweight on Ion...
10/30/2025 18:19:29

Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price targ...

Barclays Maintains Overweight on Ionis Pha...
10/30/2025 16:19:58

Barclays analyst Gena Wang maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price target from ...

HC Wainwright & Co. Maintains Buy on Ionis...
10/30/2025 16:17:12

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the p...

RBC Capital Maintains Outperform on Ionis ...
10/30/2025 15:19:00

RBC Capital analyst Luca Issi maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Outperform and raises the price target fr...

Raymond James Reiterates Strong Buy on Ion...
10/30/2025 15:00:19

Raymond James analyst Gary Nachman reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Strong Buy and raises the price tar...

alphabet-to-rally-around-22-here-are-10-top-analyst-forecasts-for-thursday

Alphabet To Rally Around 22%? Here Are 10 ...
10/30/2025 11:36:08

Needham Maintains Buy on Ionis Pharmaceuti...
10/30/2025 10:19:49

Needham analyst Joseph Stringer maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target from $7...

Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

Ionis Pharmaceuticals Raises FY2025 Sales ...
10/29/2025 11:03:05

Ionis Pharmaceuticals (NASDAQ:IONS) raises FY2025 sales outlook from $825.000 million-$850.000 million to $875.000 million-$900...

Ionis Pharmaceuticals Q3 Adj. EPS $(0.61) ...
10/29/2025 11:02:40

Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of...

Ionis Pharmaceuticals Earnings Preview
10/28/2025 18:02:36

Ionis Pharma To Present Detailed Data From...
10/27/2025 11:13:29

– Ionis to host webcast on Saturday, November 8 at 3:00 p.m. ET to discuss results –Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) t...

31 Analysts Assess Ionis Pharmaceuticals: ...
10/16/2025 20:01:18

Morgan Stanley Maintains Overweight on Ion...
10/16/2025 17:58:07

Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price targ...

Needham Maintains Buy on Ionis Pharmaceuti...
10/08/2025 16:24:20

Needham analyst Joseph Stringer maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target from $7...

Oppenheimer Maintains Outperform on Ionis ...
10/08/2025 15:51:23

Oppenheimer analyst Jay Olson maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Outperform and raises the price target fr...